Cargando…
Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi
Importance: The protective efficacy of COVID-19 vaccinations has declined over time such that booster doses are required. Objective: To evaluate the efficacy and adverse events of booster doses of two inactivated COVID-19 vaccines. Design: This is a double-blind, randomized, placebo-controlled phase...
Autores principales: | Al Kaabi, Nawal, Yang, Yunkai, Eldin Hussein, Salah, Yang, Tian, Abdalla, Jehad, Wang, Hui, Lou, Zhiyong, Bakkour, Agyad, Arafat, Afnan, Jiang, Zhiwei, Tian, Ye, Xiao, Peng, Zaher, Walid, Eltantawy, Islam, Wang, Chenlong, Xu, Guangxue, Zhang, Yuntao, Yang, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962595/ https://www.ncbi.nlm.nih.gov/pubmed/36851177 http://dx.doi.org/10.3390/vaccines11020299 |
Ejemplares similares
-
Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates
por: Al Kaabi, Nawal, et al.
Publicado: (2022) -
Clinical and laboratory characteristics of patients hospitalised with COVID-19: clinical outcomes in Abu Dhabi, United Arab Emirates
por: Al Harbi, Mariam, et al.
Publicado: (2022) -
Human brucellosis in the Emirate of Abu Dhabi, United Arab Emirates, 2010–2015
por: Al Shehhi, Nawal, et al.
Publicado: (2016) -
Diagnostic Testing for Diabetes Using HbA(1c) in the Abu Dhabi Population: Weqaya: the Abu Dhabi Cardiovascular Screening Program
por: Hajat, Cother, et al.
Publicado: (2011) -
A profile and approach to chronic disease in Abu Dhabi
por: Hajat, Cother, et al.
Publicado: (2012)